OBJECTIVE: To explore patients' views and expectations regarding their first prescription for benzodiazepines (BZDs). DESIGN: Qualitative study using semistructured interviews. SETTING: Patients were recruited from general practices in the regions of Ghent and Brussels in Belgium and were interviewed at home. PARTICIPANTS: Fifteen family practice patients who had received prescriptions for BZDs for the first time. METHOD: Interviews were audiotaped and transcribed verbatim. Data were analyzed by themes using a phenomenologic approach. MAIN FINDINGS: Patients had asked their physicians for "something" because they thought they were in serious distress and needed help. They seemed to feel a conflict between the need for medication and the negative connotations surrounding BZD use. Patients used 2 strategies to justify consumption of BZDs: maximizing their problems and minimizing use. Patients knew very little about the medication and did not ask about it. Their expectations regarding continued use were vague, even though they seemed to be aware of the risk of psychological dependency and conditioning mechanisms. Patients did not actively ask for nonpharmacologic alternatives, but when they were offered them, their attitudes toward them were generally positive. CONCLUSION: First-time BZD users ask for help with distress, but place the responsibility for solving their problems on their family physicians. Even when short-term users were aware of the concept of psychological dependency, they did not feel the need for more information. Physicians should develop communication strategies to persuade their patients that they take the patients' problems seriously even though consultations do not always end with prescriptions. It is important that doctors clearly explain the risks and benefits of starting BZD treatment and set limits from the start. This will help doctors manage first-time BZD users more effectively and will help patients avoid chronic use.
OBJECTIVE: To explore patients' views and expectations regarding their first prescription for benzodiazepines (BZDs). DESIGN: Qualitative study using semistructured interviews. SETTING:Patients were recruited from general practices in the regions of Ghent and Brussels in Belgium and were interviewed at home. PARTICIPANTS: Fifteen family practice patients who had received prescriptions for BZDs for the first time. METHOD: Interviews were audiotaped and transcribed verbatim. Data were analyzed by themes using a phenomenologic approach. MAIN FINDINGS:Patients had asked their physicians for "something" because they thought they were in serious distress and needed help. They seemed to feel a conflict between the need for medication and the negative connotations surrounding BZD use. Patients used 2 strategies to justify consumption of BZDs: maximizing their problems and minimizing use. Patients knew very little about the medication and did not ask about it. Their expectations regarding continued use were vague, even though they seemed to be aware of the risk of psychological dependency and conditioning mechanisms. Patients did not actively ask for nonpharmacologic alternatives, but when they were offered them, their attitudes toward them were generally positive. CONCLUSION: First-time BZD users ask for help with distress, but place the responsibility for solving their problems on their family physicians. Even when short-term users were aware of the concept of psychological dependency, they did not feel the need for more information. Physicians should develop communication strategies to persuade their patients that they take the patients' problems seriously even though consultations do not always end with prescriptions. It is important that doctors clearly explain the risks and benefits of starting BZD treatment and set limits from the start. This will help doctors manage first-time BZD users more effectively and will help patients avoid chronic use.
Authors: Rolf van Hulten; Arnold B Bakker; Aart C Lodder; K Bart Teeuw; Albert Bakker; Hubert G Leufkens Journal: Soc Sci Med Date: 2003-03 Impact factor: 4.634
Authors: Wim Gorgels; Richard Oude Voshaar; Audrey Mol; Eloy Van De Lisdonk; Jan Mulder; Henk Van Den Hoogen; Anton Van Balkom; Marinus Breteler; Frans Zitman Journal: Scand J Prim Health Care Date: 2008 Impact factor: 2.581
Authors: Viviam Vargas Barros; Emérita Sátiro Opaleye; Marcelo Demarzo; Daniela Fernández Curado; Sarah Bowen; Helena Hachul; Ana Regina Noto Journal: Int J Behav Med Date: 2021-05-19
Authors: Stephanie Heinemann; Vivien Weiß; Kati Straube; Roland Nau; Thomas Grimmsmann; Wolfgang Himmel; Eva Hummers-Pradier Journal: BMJ Open Date: 2016-08-05 Impact factor: 2.692
Authors: Víviam Vargas Barros; Emérita Sátiro Opaleye; Marcelo Demarzo; Sarah Bowen; Daniela Fernández Curado; Helena Hachul; Ana Regina Noto Journal: PLoS One Date: 2018-03-16 Impact factor: 3.240